about
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial CarRationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancerThromboprophylaxis with fondaparinux in high-risk postoperative patients with renal insufficiency.Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer.Miniature microwave applicator for murine bladder hyperthermia studies.Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study.Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study.Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review.Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer.Costimulation, coinhibition and cancer.Increased optical magnification from 2.5x to 4.3x with technical modification lowers the positive margin rate in open radical retropubic prostatectomy.Dynamic prediction of metastases after radical prostatectomy for prostate cancer.A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancerNCCN Guidelines Insights: Bladder Cancer, Version 2.2016.Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma.CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.Novel immunotherapeutic strategies in development for renal cell carcinoma.Anticipatory Positive Urine Tests for Bladder Cancer.Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer.Unilateral vesicoureteral reflux: does endoscopic injection based on the cystoscopic appearance of the ureteral orifice decrease the incidence of de-novo contralateral reflux?Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers.Soluble B7-H1: differences in production between dendritic cells and T cells.Report of a rare fistula between a Studer neobladder and external iliac artery.Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL.Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer.Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality.Note on "simulation optimization of PSA-threshold based prostate cancer screening policies".Is tumor response important for renal carcinoma?Words of wisdom. Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year verRe: Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.Interpreting a study on bladder cancer screening.Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.Maintenance bacillus Calmette-Guérin: why is there continued debate?Is the location of a positive surgical margin after radical prostatectomy important for prognosis?Obstructive Sleep Apnea Associated With Erectile Dysfunction and Cardiovascular Disease–Reply–I.
P50
Q30975386-34765A74-D489-43D0-87AC-117B2F491A10Q33711531-1D8C73FE-A448-4EB9-9F75-9A6122D9351DQ34145171-26F43D5C-4431-427E-9DEA-9438CAA40448Q34147801-99195B75-0DD5-4BB4-B534-3061B8271F8DQ34300948-78DD7468-3E6D-4039-996D-C82D080BC410Q34667806-192D6DFC-BA03-434E-8EE9-6B19EEF4827AQ35619699-A41493DB-AB5A-4D3A-AF25-A28A18C0DE5DQ35678685-38C8BA0B-C504-4E6D-AEBC-9ED61BB0DB77Q35965693-6CAFD9D0-9593-4EE7-999C-E08691F96893Q36672424-D3677AE5-94FC-4E8D-9167-9B8E9C9E1C1CQ36737690-3E1B2BD1-7408-494A-A361-739E53E718F8Q36998781-DEE60552-3D10-4ABE-8504-5C91DD03DE7DQ37637096-F8662ED7-9702-42DF-B28C-7A7E7055D500Q37735465-C8F1D2FE-E4B6-40E6-A894-5BF97A1765C4Q37736774-77904B7F-F214-40B9-9E86-C82F9D7DD368Q37852713-AE8618B3-C93D-456C-BD7C-A6472AAC4E25Q37892578-58BCC775-492A-4DDA-B97B-EEF66474152FQ38053636-E447F676-09F4-465A-9AA2-702120D43A23Q38772051-708C9EDD-AD8A-4887-A99D-9670CCFDAE78Q39024940-58800B67-3B76-485D-B6F4-6842614A9984Q39210779-D7D01D18-0B40-4CDC-BD32-FAB56EF528EEQ39288166-022605D3-2CB5-4187-B1D2-D57E50F39ECCQ40309109-3EBC9E3B-8FB2-45E6-A298-23F66AB5DC5DQ41448543-9FE34498-91B4-4746-9312-E606E12CA7A5Q41762691-1953B4D1-172D-4F12-8B12-663A422C5552Q41861433-85E33857-BA07-46C7-93CC-CC1F894CA88FQ42049239-2D99841D-3691-4C2E-9D43-452897537965Q42619579-FFB0C5A1-72DE-4AE1-AB2A-D1C903FE68EDQ43938660-C093D164-7645-4656-8EB4-36126A3393C4Q44242886-711B9818-D62C-408F-AC8C-835816C217B3Q44331255-0E6DACC4-7B1B-4716-BD88-339D97384343Q44493365-C4543749-81E3-4D0C-A1DB-3F9A19230EF5Q44666671-C76766FB-FADE-4863-A9BB-58F35743EB74Q45014271-013F61FA-8CCB-4FEB-B4EC-EED6F7D43723Q45030715-CFF790A5-F41B-4A2B-B330-C628DE6A71A0Q45051104-CD5D2C1D-AEBF-48FE-AF28-ED60F9495720Q45250550-166FEACF-5B89-44A8-BC84-201197904C26Q45420362-0CF2E45C-45B9-4798-86CC-BD8C879E3D64Q45800372-CE18E9C7-4B8F-4853-8244-CA4C2DA31900Q45922612-C83A16A3-9800-46C1-8B39-7F5D085D0476
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Brant A Inman
@es
Brant A. Inman
@en
Brant A. Inman
@nl
Brant A. Inman
@sl
type
label
Brant A Inman
@es
Brant A. Inman
@en
Brant A. Inman
@nl
Brant A. Inman
@sl
altLabel
Brant Inman
@en
prefLabel
Brant A Inman
@es
Brant A. Inman
@en
Brant A. Inman
@nl
Brant A. Inman
@sl
P106
P108
P1153
13103458500
P21
P31
P496
0000-0002-6060-4485
P569
2000-01-01T00:00:00Z